Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cannabis
Biotech
Aelis' cannabis use drug flops, Indivior rethinks $100M option
Aelis reported the failure of a phase 2b cannabis use disorder study, prompting its partner Indivior to say it doesn’t expect to exercise its option.
Nick Paul Taylor
Sep 4, 2024 5:04am
Maridose rolls out CRO focused on cannabis-based drug trials
Dec 14, 2023 8:07am
Anebulo lifts lid on midphase cannabis intoxication therapy data
Sep 26, 2022 7:56am
